These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11329054)

  • 1. Molecular targets for breast cancer therapy and prevention.
    Bange J; Zwick E; Ullrich A
    Nat Med; 2001 May; 7(5):548-52. PubMed ID: 11329054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer: the role of angiogenesis and antiangiogenic therapy.
    Miller KD; Dul CL
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1071-86, ix. PubMed ID: 15474336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets as therapeutic strategies in the management of breast cancer.
    Sartor CI
    Semin Radiat Oncol; 2002 Oct; 12(4):341-51. PubMed ID: 12382192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
    Morabito A; Sarmiento R; Bonginelli P; Gasparini G
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
    Ademuyiwa FO; Miller KD
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cancer therapies.
    Blay JY; Le Cesne A; Alberti L; Ray-Coquart I
    Bull Cancer; 2005 Feb; 92(2):E13-8. PubMed ID: 15749638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for locally advanced breast cancer.
    Specht J; Gralow JR
    Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-based therapies in breast cancer: current status and future perspectives.
    Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
    Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy.
    Fantini MC; Becker C; Neurath MF
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):681-94. PubMed ID: 16111468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of novel targeted therapies into the systemic treatment of breast cancer--a review.
    Tsakonas G; Kosmas C
    J BUON; 2007; 12(3):319-27. PubMed ID: 17918284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous angiogenesis inhibitors.
    Folkman J
    APMIS; 2004; 112(7-8):496-507. PubMed ID: 15563312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histoenzymatic and immunohistochemical study during antiangiogenetic treatment in breast cancer cells.
    Pallag A; Ardelean A; Roşca E; Pop O; Suciu R
    Rom J Morphol Embryol; 2011; 52(1 Suppl):403-7. PubMed ID: 21424083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
    Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
    Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis inhibitors in cancer therapy.
    Dredge K; Dalgleish AG; Marriott JB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in adjuvant therapy for breast cancer.
    Slamon DJ; Romond EH; Perez EA;
    Clin Adv Hematol Oncol; 2006 Mar; 4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16736568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic therapy in the management of breast cancer.
    Wu Y; Sun WL; Feng JF
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
    Roy V; Perez EA
    Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.